Tolebrutinib in nonrelapsing SPMS: regulatory divergence and the limits of relapse based labels. Niu T, Li J, Wang Q, Wang G Mult Scler Relat Disord. 2026 Aug 02; 114:107421. PMID: 42567027. Abstract CommentRecommendBookmarkWatch
